Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,451 | 29,309 | 30,863 | 49,744 | 68,520 |
| Receivables | 18,320 | 13,732 | 15,666 | 15,412 | 25,423 |
| Inventories | 20,825 | 24,498 | 25,074 | 21,892 | 19,689 |
| TOTAL | $72,066 | $73,465 | $78,206 | $96,327 | $117,663 |
| Non-Current Assets | |||||
| PPE Net | 28,034 | 28,913 | 27,718 | 23,784 | 17,531 |
| Intangibles | 134,306 | 137,420 | 140,568 | 143,456 | 146,769 |
| Other Non-Current Assets | 40,808 | 42,390 | 42,823 | 41,631 | 42,794 |
| TOTAL | $203,148 | $208,723 | $211,109 | $208,871 | $207,094 |
| Total Assets | $275,214 | $282,188 | $289,315 | $305,198 | $324,757 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,838 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 10,602 | 10,786 | 11,224 | 12,552 | 9,220 |
| Accrued Expenses | 4,920 | 8,286 | 8,293 | 8,693 | 13,787 |
| TOTAL | $49,568 | $47,290 | $52,848 | $53,529 | $54,249 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,049 | 9,993 | N/A | N/A | N/A |
| Deferred Revenues | 15,482 | 17,157 | 21,678 | 14,222 | 16,387 |
| Other Non-Current Liabilities | 92,590 | 93,175 | 93,280 | 92,630 | 93,735 |
| TOTAL | $131,050 | $135,561 | $127,017 | $128,731 | $131,458 |
| Total Liabilities | $180,618 | $182,851 | $179,865 | $182,260 | $185,707 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,199 | 76,486 | 76,167 | 74,963 | 74,547 |
| Common Shares | 77 | 76 | 76 | 75 | 75 |
| Retained earnings | -735,998 | -726,568 | -712,725 | -695,582 | -676,761 |
| Other shareholders' equity | -907 | -730 | -284 | -331 | 112 |
| TOTAL | $94,596 | $99,337 | $109,450 | $122,938 | $139,050 |
| Total Liabilities And Equity | $275,214 | $282,188 | $289,315 | $305,198 | $324,757 |